A multicentre, randomised, double-blind, parallel group, phase IV study to compare the renal effects of the non-ionic iso-osmolar contrast medium, iodixanol 320 mg I/mL VisipaqueTM , with the non-ionic low osmolar contrast medium, iopamidol 300 mg I/mL, in subjects with impaired renal function and diabetes mellitus undergoing multidetector-row helical CT

• Conditions: ephropathy; MedDRA version: 6.1Level: PTClassification code 10029155

• Registration Number: EUCTR2005-000087-12-IT
• Lead Sponsor: AMERSHAM HEALTH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-19
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified